Trials / Not Yet Recruiting
Not Yet RecruitingNCT07478679
Radiation to Treat Joint Damage Caused by Cancer Immunotherapy
Use of Low-Dose RADiotherapy in the Management of Immune Checkpoint- Inhibitor-ArThropathy as an Immune-Related Adverse Event (RADIATE)
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- University of Chicago · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
This study will prospectively investigate the feasibility and safety of administering LDRT in patients with immunotherapy-induced inflammatory arthritis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Low dose radiation therapy | 0.5 Gy per treatment x 6 treatments, given 2-3 treatments per week over 2-3 weeks (Can be given concurrently with IO) |
Timeline
- Start date
- 2026-08-26
- Primary completion
- 2028-09-17
- Completion
- 2028-09-17
- First posted
- 2026-03-17
- Last updated
- 2026-03-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07478679. Inclusion in this directory is not an endorsement.